Last updated on April 2019

A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis


Brief description of study

The purpose of this study is to compare the efficacy and safety of ixekizumab to guselkumab in participants with moderate-to-severe plaque psoriasis.

Clinical Study Identifier: NCT03573323

Contact Investigators or Research Sites near you

Start Over

Mindful Medical Research

San Juan, Puerto Rico
1.11miles
  Connect »

GCM Medical Group PSC

San Juan, Puerto Rico
1.85miles
  Connect »

Office of Dr. Alma M. Cruz

Carolina, Puerto Rico
7.39miles
  Connect »

Santa Cruz Behavioral PSC

Bayamón, Puerto Rico
7.89miles
  Connect »

Centro Reumatologico de Caguas

Caguas, Puerto Rico
8.92miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.